BackGeneDx Holdings Overview

GeneDx Holdings Current Cash

Track GeneDx Holdings's current cash ($94M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$93.92M
↓ 5.80% YoYΔ $-5.78M vs prior year quarter

Peer average

Loading

GeneDx Holdings Current Cash History

Loading

GeneDx Holdings vs. peers: Current Cash Comparison

Loading

GeneDx Holdings Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

GeneDx Holdings (SMFR) FAQ

GeneDx Holdings (SMFR) currently reports a current cash of $94M as of March 2026. That compares with $100M in the prior-year period — down 5.8% year over year. Use the charts on this page to explore GeneDx Holdings's current cash history and peer comparisons.

GeneDx Holdings's current cash decreased from $100M to $94M — a 5.8% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

GeneDx Holdings reported $94M in current cash as of March 2026. That compares with $100M in the prior-year period — down 5.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $94M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for GeneDx Holdings, and consider following SMFR for alerts when major investors trade the stock.

GeneDx Holdings is classified in the Healthcare sector. On current cash, it currently shows $94M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SMFR with unrelated industries.